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D90131 DoesIschemicPreconditioning(1P)RequireReperfueionBeforetheSustainedIschemis?
B. Korbmacher,T. Schmidt, U. Schwanke, G. Arnold, E. Gains,
,J.D. Schipke, R. Schulz, G. Heusch. C/ir?icof Tfroracicand Cardiovasc.
.%rgery Inst. of Exper. Surgery Univ. Dtisaeldorf, Germarr~ Inst. of
PathophysiobgK Uni~ Essen, Germany
1P is generally thought to be initiated through several bouts of ischemia
and reperfusion that precede a prolonged ischemic event. To test whether
a reperfusion period must precede this final ischemic event, one series
without reperfuaion (intraischemic preconditioning: 11P)was compared to
conventional 1P(CIP). Methods: Experiments were performed on 19 isolated
rabbit hearts that were connected to a modified Langendorff apparatus. The
hearts were perfused with an erythrocyte suspension (Het= 30%; Ca2+= 1.8
mM). Protocol: (1) control series (n = 5): 80 min normal flow -+ 60 min low
flow (10%) ischemia + 60 min reperfusion. (2) CIP series (n = 7): control -+
4 times 5 min of zero flow with 10 min reperfusion + 60 min low flow (10%)
iechemia + 60 min repeffusion. (3) IIP series (n = 7): control + 50 min
normal flow -+ 10 min no flow -+ 60 min low flow (10%) ischemia + 60 min
reperfusion. At the end of each protocol, the hearts were cut into 6 to 9 slices
and stained with TTC. The infarcted area was assessed by computer-aided
planimetry. Results: (means l SD): The infarct size in control hearts was
6.3 & 3.7% from LV total cardiac mass, in CIP hearts 2.6 * 1.6Y0and in
the HP hearts 3.1 * 1.37.. In the model used, CIP exerted a statistically
significant (p < 0.05) protective effect. HPexerted a similar effect that was,
however, less pronounced. In the model used, the preconditioning effect
appears to not depend on reperfusion and thua, the protective mechanism
of preconditioning to develop during the initial ischemia that precedes the
sustained ischemia. Alternatively, low flow ischemia always encompasses
some reperfusion.
D90132 Identificationof5 Hypoxis-inducibleRNA-ProteinBindingSitesConservedinRstandHuman
VascularEndothelialGrowthFactormRNA
A.P.Levy, N.S. Levy, M.A. Goldberg. Georgetown University Medicai Centec
Washington DC, USA, Brigham and Women’s Hospital, Boston, MA, USA
The hypoxic induction of vascular endothelial growth factor (VEGF), a po-
tent angicgenic factor, is due in large part to an increase in the stability of
ita mRNA. We have previously demonstrated the presence of a hypoxia-
inducible protein complex (HIPC) which binds to a region of the 3’ untrans-
lated ragion (UTR) of the rat gene for VEGFthat iscritieel for the stabilization
of VEGF mRNA in an in vitro RNA degradation assay. In order to identify
other ragions of functional importance in the 3’ UTR of VEGF mRNA we se-
quenced the corresponding region for the human VEGF gene and compared
it with the rat sequence. We found that all four petential polyadenylation sites
are conserved as are thefwo mnsensus nonameric (UUAUUUAUU) instabil-
ity elements that we have previously shown to mediate the rapid turnover of
VEGF mRNA under normoxic conditions. Alignment of the region previously
shown for rat VEGF mRNA to be critical for its stabilization by hypoxia with
the eomespondinghuman VEGF mRNA sequence demonstrated a greater
than 907. sequence homology. Furthermore, RNA electromobiiity shift aa-
say (EMSA) identified five HIPC binding sites in the human and rat VEGF
3’ UTR that are conserved. RNA EMSA cross-competition studies between
each of the HIPC binding sites demonstrated that they are each Capable
of independently binding a similar if not identical HIPC. Theae data further
support the role of this HIPC in mediating the stabilization of VEGF mRNA
by hypoxia and represent a critical step in developing novel new strategies
to treat human conditions resulting from vascular insufficiency.
1901-33]ReguiarEthanOi~OnSumptiOnprOteCtS*~ainet
Myocsrdislschemia-ReperfusionI juryby
Aotivstionof ProteinKinaseC
M. Miyamae, S.A. Camacho, M.W. Weiner, V.M. Figueredo. University of
Ca/ifOmia,San Francisco, CA, USA
Recent studies suggest that regukw ethanol intake (EtOH) improves out-
comes after coronary events. Attenuation of ischemia-reperfusion (IR) injury,
as seen with ischemic preconditioning, is a mechanism which could ac-
count for these improved outcomes. Therefore we tested the hypotheses
that 1) EtOH attenuates IR injury, and 2) this protective effect is medi-
ated by activation of protein kinase C (PKC). Guinea pigs were pair-fed
nutritionally supplemented liquid diets (calorically matched) with 15 or O%
ethanol-derived calories for 10 weeks. Perfuaed hearts were subjected to 45
min global ischemia and 46 min reperfusion in the presence or absence of
the PKC inhibitor, chelerythrine (CHE, 10 #M). LV function was monitored by
LV developed (LVP) and diastolic (LVEDP) pressures. Release of creatine
kinase (CK) was uaed as an index of myocyte injufy. Results.’Body weights
of EtOH and controls (CTL) were not different. After IR, EtOH had a greater
recove~ of LVP,less rise of LVEDP and less CK release, compared to CTL.
CHE abolished the cardioprotective effect of EtOH. Conclusion.’EtOH atten-
uates myocardial IR injury through PKC activation, in a manner analogous to
ischemic preconditioning.
Pre-iachemia 48minReperfusion
LVP(mmHg) LVEDP(mmHg) LVP LVEDP CK(U/g.ml)
cn 117*4 to+o 25& 4 58&5 469&74
EtOH 117+2 10+0 49& 4“ 35h 6* 260+40”
CTL + CHE 121 *3 10*O 24* 3 53*4 464 l44
EtOH+ CHE 116+3 10*O 30+ 3 49*4 415+ 42
(mean+ SEM,*p c 0.05vs.CTL,n= 9 foreachgroup)
